Effects of Schistosoma mansoni and praziquantel treatment on the lower gastrointestinal mucosa: a cohort study in Tanzania

Pham, K.; Mtalitinya, G.S.; Aristide, C.; Airewele, E.A.; Nyakaru, D.K.; McMahon, P.; ... ; Downs, J.A. (2022)

Article / Letter to editor

Schistosomes infect over 200 million people worldwide, but few studies have characterized the effects of Schistosoma mansoni infection and effective treatment on the lower gastrointestinal mucosa. In this prospective cohort study, we compared the clinical findings on sigmoidoscopy and laboratory measures in Tanzanian adults with and without S. mansoni infection at baseline and 6 months after praziquantel treatment. Grading of the endoscopic findings was done using the Mayo Scoring System for Assessment of Ulcerative Colitis Activity. Schistosome infection was confirmed by stool microscopy and serum circulating anodic antigen (CAA). Baseline comparisons were performed in Stata using Fisher's exact and Wilcoxon rank-sum tests, and pre- and posttreatment comparisons using Wilcoxon matched-pairs signed-rank and McNemar's tests.We investigated the clinical characteristics of 48 individuals: 32 with and 16 without S. mansoni infection. Infected individuals had greater severity of sigmoid and rectal mucosal abnormalities and higher Mayo scores and serum eosinophils (all p < 0.05) than uninfected individuals at initial evaluation. At 6 months, 28 individuals completed repeat blood tests and sigmoidoscopy. Of these, 14 cleared their baseline infection (n = 7) or experienced a greater than 7-fold decrease in serum CAA (n = 7). Follow-up sigmoidoscopies revealed some improvements in sigmoid and rectal mucosal findings, although Mayo scores were not significantly lower. Both the median erythrocyte sedimentation rates (32.5 -> 12.5 mm/hr) and percent of eosinophils (7.1 -> 3.1%) decreased in this group from baseline to follow-up.S. mansoni infection was associated with mild-to-moderate lower gastrointestinal mucosal abnormalities that were grossly visible during sigmoidoscopy, and these improved partially 6 months after effective treatment with praziquantel. Additional studies, of longer duration and focused on both clinical and mucosal immunologic effects of S. mansoni, could provide additional insight.

• Schistosoma mansoni
• Gastrointestinal tract
• Sigmoidoscopy
• Praziquantel

• All authors: Pham, K.; Mtalitinya, G.S.; Aristide, C.; Airewele, E.A.; Nyakaru, D.K.; McMahon, P.; Mulaki, G.M.; Corstjens, P.L.A.M.; Dood, C.J. de; Dam, G.J. van; Changalucha, J.M.; Mazigo, H.D.; Lee, M.H.; Jaka, H.; Downs, J.A.
• Date: 2022-12-01
• Journal: Acta Tropica
• Volume: 238
• DOI: doi:10.1016/j.actatropica.2022.106752
• Link: https://www.sciencedirect.com/science/article/pii/S0001706X22004442?via%...